Longevity Health Holdings, Inc. Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities
Longevity Health Holdings, Inc. (XAGE) reported Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities of $199.48 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities · last filed 2026-08-14
- Longevity Health Holdings, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-06-30 was $184.37K, a 58.39% decline year-over-year.
- Longevity Health Holdings, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2026-03-31 was $15.11K, a 89.88% decline year-over-year.
- Longevity Health Holdings, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-12-31 was $845.60K.
- Longevity Health Holdings, Inc. increase (decrease) in accrued liabilities and other operating liabilities for the quarter ending 2025-09-30 was $77.82K.
- Longevity Health Holdings, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2025 was $1.52M.
- Longevity Health Holdings, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2024 was -$1.28M, a 324.78% decline from fiscal 2023.
- Longevity Health Holdings, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2023 was $570.22K, a 32.67% increase from fiscal 2022.
- Longevity Health Holdings, Inc. increase (decrease) in accrued liabilities and other operating liabilities for fiscal 2022 was $429.79K.
| Period end | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 3 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 6 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $184.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $199.48K 10-Q · filed 2026-08-14 | $1.05M derived: sum of 3 quarters · filed 2026-08-14 | $1.12M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $15.11K 10-Q · filed 2026-05-15 | $860.71K derived: sum of 2 quarters · filed 2026-05-15 | $938.53K derived: sum of 3 quarters · filed 2026-05-15 | $1.38M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | $845.60K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $923.41K derived: sum of 2 quarters · filed 2026-03-31 | $1.37M derived: sum of 3 quarters · filed 2026-08-14 | $1.52M 10-K · filed 2026-03-31 | |
| 2025-09-30 | $77.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $520.95K derived: sum of 2 quarters · filed 2026-08-14 | $670.35K 10-Q · filed 2025-11-14 | $649.49K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | $443.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $592.53K 10-Q · filed 2026-08-14 | $571.67K derived: sum of 3 quarters · filed 2026-08-14 | $570.62K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $149.39K 10-Q · filed 2026-05-15 | $128.54K derived: sum of 2 quarters · filed 2026-05-15 | $127.48K derived: sum of 3 quarters · filed 2026-05-15 | -$105.24K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | -$20.86K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$21.91K derived: sum of 2 quarters · filed 2026-03-31 | -$254.63K derived: sum of 3 quarters · filed 2026-03-31 | -$1.28M 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$1.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$233.78K derived: sum of 2 quarters · filed 2025-11-14 | -$1.26M 10-Q · filed 2025-11-14 | -$961.89K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | -$232.72K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$1.26M 10-Q · filed 2025-08-14 | -$960.84K derived: sum of 3 quarters · filed 2025-08-14 | -$1.36M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | -$1.03M 10-Q · filed 2025-05-15 | -$728.12K derived: sum of 2 quarters · filed 2025-06-17 | -$1.13M derived: sum of 3 quarters · filed 2025-06-17 | -$794.13K derived: sum of 4 quarters · filed 2025-06-17 | |
| 2023-12-31 | $298.97K derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-06-17 | -$98.44K derived: sum of 2 quarters · filed 2025-06-17 | $232.96K derived: sum of 3 quarters · filed 2025-06-17 | $570.22K 10-K/A · filed 2025-06-17 | |
| 2023-09-30 | -$397.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$66.01K derived: sum of 2 quarters · filed 2024-11-14 | $271.25K 10-Q · filed 2024-11-14 | -$2.11M 10-Q · filed 2023-11-15 | -$28.55K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $331.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $668.66K 10-Q · filed 2024-08-14 | $368.86K derived: sum of 3 quarters · filed 2024-08-14 | ||
| 2023-03-31 | $337.26K 10-Q · filed 2024-05-15 | $37.46K derived: sum of 2 quarters · filed 2024-05-15 | |||
| 2022-12-31 | -$299.80K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $429.79K 10-K · filed 2024-04-01 | |||
| 2022-09-30 | $729.59K 10-Q · filed 2023-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STEPAN CO (SCL) | United States | $1.451B | -477.05 |
| CHURCH & DWIGHT CO INC /DE/ (CHD) | United States | $22.622B | 30.81 |
| ECOLAB INC. (ECL) | United States | $77.183B | 36.58 |
| PROCTER & GAMBLE Co (PG) | United States | $338.763B | 21.26 |